Drugs / INDIUM PENTETREOTIDE
INDIUM PENTETREOTIDE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00442533 | Aug 2005 → Aug 2014 | neuroendocrine neoplasm | Radio Isotope Therapy of America | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00944372 | Jul 2003 → Aug 2005 | cancer | Mallinckrodt | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INDIUM PENTETREOTIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | (sup 111)indium pentetreotide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | 111indium pentetreotide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | Indium (111 in) pentetreotide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | Indium In-111 pentetreotide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00944372 ↗ |
| Known as | Indium in-111 pentetreotide kit | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | Indium-111 pentetreotide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00442533 ↗ |
| Known as | MP-1727 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | Octreoscan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Known as | Pentetreotide 111in chelate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110556 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2110556 ↗ |
| Route | Intravenous | “Single intravenous injection” NCT00944372 ↗ |